Company intelligence
Okomera
We turn tumor response into treatment decisions.
Biotechnology Research
Paris, FR
24 employees
Founded 2020
1 public signals
About Okomera
Okomera has developed a proprietary technology platform that transforms patient biopsies into multiple miniaturized tumor avatars, enabling rapid assessment of treatment response in real-world conditions. Designed as a decentralized lab for clinicians and biopharma companies, the platform seamlessly converges cutting-edge hardware, software, and biological technologies into a single integrated system, making functional precision medicine accessible at scale. We are building a future where every cancer patient receives the right treatment from the start.
Verified activity
Signals from Okomera
1 published signal